Amgen · Operating Cash Flow (Statement)

Latest reported$12.48Bperiod endingJun 30, 2026

AMGN Cash from Operations (-$5.90M → $12.48B)

Annual operating cash flow (statement)

High-resolution chart · PNG

AMGN operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	9,958,000,000
Dec 31, 2024	11,490,000,000
Dec 31, 2023	8,471,000,000
Dec 31, 2022	9,721,000,000
Dec 31, 2021	9,261,000,000
Dec 31, 2020	10,497,000,000
Dec 31, 2019	9,150,000,000
Dec 31, 2018	11,296,000,000
Dec 31, 2017	11,177,000,000
Dec 31, 2016	10,354,000,000
Dec 31, 2015	9,077,000,000
Dec 31, 2014	8,555,000,000
Dec 31, 2013	6,291,000,000
Dec 31, 2012	5,882,000,000
Dec 31, 2011	5,119,000,000
Dec 31, 2010	5,787,000,000
Dec 31, 2009	6,336,000,000
Dec 31, 2008	5,988,000,000
Dec 31, 2007	5,401,000,000
Dec 31, 2006	5,389,000,000
Dec 31, 2005	4,911,000,000
Dec 31, 2004	3,697,000,000
Dec 31, 2003	3,566,600,000
Dec 31, 2002	2,248,800,000
Dec 31, 2001	1,480,200,000
Dec 31, 2000	1,634,600,000
Dec 31, 1999	1,075,300,000
Dec 31, 1998	1,041,500,000
Dec 31, 1997	902,900,000
Dec 31, 1996	822,600,000
Dec 31, 1995	773,200,000
Dec 31, 1994	531,900,000
Dec 31, 1993	433,000,000
Dec 31, 1992	292,800,000
Dec 31, 1991	219,700,000
Dec 31, 1990	13,500,000
Dec 31, 1989	18,700,000
Dec 31, 1988	-5,900,000